investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Ming Tan
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Oystein Fodstad
University of Oslo
Oslo, Norway
Ming Tan
University of South Alabama
Mobile, United States
Related projects
Dario Marchetti
Heparanase Mechanisms in Brain-metastatic Breast Cancer
Breast
Smita Bhatia
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
Breast
Radiation Oncology
Pediatric oncology or childhood cancer
C Marcelo Aldaz
Characterization of WWOX, the Cancer Gene Spanning FRA16D
Breast
Donald W. Kufe
Oncogenic Signaling by DF3/MUC1 in Human Breast Cancer
Breast
David E Goldgar
A Comprehensive Approach to Breast Cancer Susceptibility Across the Risk Spectrum
Breast
Xuebiao Yao
Function of ACAP4 in CCL18-Stimulated Breast Cancer Metastasis
Breast
Antonio Fojo
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
Breast
David Salomon
The Role of Cripto in the Pathogenesis of Breast and Colon Cancer
Breast
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast